ODAC 30% Off Registration, Use Code: JDD30
Skip to main content
AestheticsFeatured Articles

What are the Skincare Benefits of Niacinamide?

By September 28, 2020No Comments

Featured Article

Featured Article

A 2016 study from Journal of Drugs in Dermatology suggests that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.

Read more

A 2016 study from Journal of Drugs in Dermatology (“Efficacy and Tolerability of a Skin Brightening/Anti-Aging Cosmeceutical Containing Retinol 0.5%, Niacinamide, Hexylresorcinol, and Resveratrol“), which was recently cited in an article on Prevention.com, suggests that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection. 

Patricia Farris MD, Joshua Zeichner MD, and Diane Berson MD

 

Consumers are increasingly interested in over-the-counter skin care products that can improve the appearance of photodamaged and aging skin. This 10-week, open-label, single- center study enrolled 25 subjects with mild to moderate hyperpigmentation and other clinical stigmata of cutaneous aging including fine lines, sallowness, lack of clarity, and wrinkling. Their mean age was 53.4±7.7 years. The test product contained retinol 0.5% in combination with niacinamide 4.4%, resveratrol 1%, and hexylresorcinol 1.1% in a moisturizing base. Subjects were provided a skin care regimen including a cleanser, hydrating serum, moisturizer, and an SPF 30 sunscreen for daily use. The test product was applied only at night.

The use of this skin brightening/anti-aging cosmeceutical was found to provide statistically significant improvements in all efficacy endpoints by study end. Fine lines, radiance, and smoothness were significantly improved as early as week 2 (P<.001). By week 4, hyperpigmentation, overall skin clarity, evenness of skin tone, and wrinkles showed statistically significant improvement compared to baseline. Mild retinoid dermatitis including flaking and redness occurred early in the study as reflected by tolerability scores. By week 10, subjects reported no stinging, itching, dryness, or tingling.

The results of this open-label clinical study suggest that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.

Read Full Article Now
Article Cited in this Post

You May Also Like

Author Spotlight: Robert Adler BA

| Author Spotlight, Featured Articles, Latest News, Psoriasis | No Comments
Check Out JDD’s Latest Author Spotlight Our current Author Spotlight features Robert Adler BA, one of the co-authors for Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors…

Photodistributed Hyperpigmentation Associated With COVID-19 Vaccination

| COVID 19, Dyspigmentation, Featured Articles, Latest News | No Comments
From the JDD Vault: Case Report on Post-COVID-19 Vaccine Photodistributed Hyperpigmentation Cutaneous reactions and rare dermatologic manifestations linked to COVID-19 vaccination remain a trending topic of discussion among clinicians. In…
Journal of Drugs in Dermatology JDD featuring video abstracts on topics like emerging hyperpigmentation therapies, modern acne algorithms, hair loss innovations, and next-generation barrier repair.

Bringing Research to Life: Watch the Experts Behind JDD’s Top Studies

| Featured Articles, Latest News, Medical Derm, Skincare | No Comments
Explore engaging Video Abstracts where leading dermatologists and researchers break down breakthrough dermatology data in their own words Staying current on clinical breakthroughs is essential, which is why JDD created…

Leave a Reply